Abstract
FDA wants pharmaceutical makers to get the clutter out of prescription-drug labeling, officials said on May 9 during an educational webcast about the new labeling rule. The new requirements, announced in January, revise the content and format of prescribing information on drug and biological
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.